Landiolol in Mitral Valve Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.
Also called NCT06793670
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,500 participants
- Sponsor
- Università Vita-Salute San Raffaele
- Registry
-
NCT06793670
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT06793670. Randomized; double masking; primary purpose prevention. Start 2025-01-28 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Landiolol in Mitral Valve Surgery
- Acronym
- LUNA
- Condition
- Cardiac Failure
- Condition
- Low Cardiac Output Syndrome
- Intervention (Drug)
- Landiolol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Università Vita-Salute San Raffaele
Record details
- Record id
cardio:ct-nct06793670- Content hash
7ed623549f90c22e87edfd79e235a02e13329a91a6bf640d3b06597993ac78da